Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: Evaluation with euglycemic clamp and oral fat load

Journal of Clinical Lipidology

Volumn 6, Issue 6, 2012, Pages 553-564

  Derosa, Giuseppe ^a   Cicero, Arrigo F G ^b   Fogari, Elena ^a   D'Angelo, Angela ^a   Bonaventura, Aldo ^a   Romano, Davide ^a   Maffioli, Pamela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Metalloproteinases; n 3 PUFAs; Oral fat load; Soluble intercellular adhesion molecule 1; Soluble vascular cell adhesion molecule 1; Tumor necrosis factor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG WITHDRAWAL; DYSLIPIDEMIA; FAT TOLERANCE TEST; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DYSLIPIDEMIAS; E-SELECTIN; EICOSAPENTAENOIC ACID; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84870294666     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.02.010     Document Type: Article

References (56)

1. J.P. Sluijter, D.P. de Kleijn, and G. Pasterkamp Vascular remodeling and protease inhibition - bench to bedside Cardiovasc Res 69 2006 595 603
2. C.M. Dollery, and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res 69 2006 625 635
3. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
4. A.K. Death, E.J. Fisher, K.C. McGrath, and D.K. Yue High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes Atherosclerosis 168 2003 263 269
5. H. Kai, H. Ikeda, and H. Yasukawa Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J Am Coll Cardiol 32 1998 368 372
6. L. Agozzino, P. Santè, and F. Ferraraccio Ascending aorta dilatation in aortic valve disease: morphological analysis of medial changes Heart Vessels 21 2006 213 220
7. G. Derosa, I. Ferrari, and A. D'Angelo Matrix metalloproteinase-2 and -9 levels in obese patients Endothelium 15 2008 219 224
8. G. Derosa, A. D'Angelo, and L. Ciccarelli Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension Endothelium 13 2006 227 231
9. G. Derosa, P. Maffioli, and A. D'Angelo Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia Clin Invest Med 32 2009 E124 E132
10. G. Derosa, A.F. Cicero, and F. Scalise Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes Endothelium 14 2007 45 51
11. G. Derosa, A.F. Cicero, and F. Scalise Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months Endothelium 14 2007 175 183
12. G. Derosa, A. D'Angelo, and F. Scalise Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome Heart Vessels 22 2007 361 370
13. J. Dyerberg, H.O. Bang, and N. Hjorne Fatty acid composition of the plasma lipids in Greenland Eskimos Am J Clin Nutr 28 1975 958 966
14. S.O. Ebbesson, P.M. Risica, and L.O. Ebbesson Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project Int J Circumpolar Health 64 2005 396 408
15. M. Ueeda, T. Doumei, and Y. Takaya Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction Heart Vessels 26 2011 145 152
16. G. Derosa, P. Maffioli, and A. D'Angelo Effects of long chain ω-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patients Exp Opin Pharmacother 10 2009 1239 1247
17. A.F. Cicero, G. Derosa, and V. Di Gregori Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study Clin Exp Hypertens 32 2010 137 144
18. P. McBride Triglycerides and risk for coronary artery disease Curr Atheroscler Rep 10 2008 386 390
19. M. Cassader, R. Gambino, and G. Ruiu Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects Aging (Milano) 8 1996 421 428
20. G. Derosa, I. Ferrari, and A. D'Angelo Oral fat load effects on inflammation and endothelial stress markers in healthy subjects Heart Vessels 24 2009 204 210
21. G. Derosa, I. Ferrari, and A. D'Angelo Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects Microvasc Res 80 2010 110 115
22. G. Derosa, A.F.G. Cicero, and E. Fogari Effects of n-3 PUFA on insulin resistance after an oral fat load Eur J Lipid Sci Technol 113 2011 950 960
23. International Lipid Information Bureau The ILIB Lipid Handbook for Clinical Practice: Dyslipidemia and Coronary Heart Disease 3rd e. 2003 International Lipid Information Bureau New York 1-242
24. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
25. R.B. McGandy, D.N.I. Hegsted, and F.J. Stare Dietary fats, carbohydrates and atherosclerotic vascular disease N Engl J Med 277 1967 245 247
26. A.H. Lichtenstein, L.J. Appel, and M. Brands Summary of American Heart Association Diet and Lifestyle Recommendations Revision Arterioscler Thromb Vasc Biol 26 2006 2186 2191
27. European Diabetes Policy Group A desktop guide to type 2 diabetes mellitus Diabetes Med 16 1999 716 830
28. L.G. Heding Determination of total serum insulin (IRI) in insulin-treated diabetic patients Diabetologia 8 1972 260 266
29. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
30. S. Klose, and K. Borner Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II) J Clin Chem Clin Biochem 15 1978 121 130
31. A.W. Wahlefeld Triglycerides determination after enzymatic hydrolysis H.U. Bermeyer, Methods of Enzymatic Analysis 2nd English ed. 1974 Academic Press, Inc New York 18 31
32. R.J. Havel, H.A. Edr, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J Clin Invest 34 1955 1345 1353
33. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
34. A.M. Witkowska, and M.H. Borawska Soluble intercellular adhesion molecule-1 (sICAM-1): an overview Eur Cytokine Netw 15 2004 91 98
35. M. Song, and J.A. Kellum Interleukin-6 Crit Care Med 33 2005 S463 S465
36. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity c-reactive protein assay Clin Chem 45 1999 2136 2141
37. K. Peter, U. Weirich, T.K. Nordt, J. Ruef, and C. Bode Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis Thromb Haemost 82 1999 38 43
38. J. Constans, and C. Conri Circulating markers of endothelial function in cardiovascular disease Clin Chim Acta 36 2006 33 47
39. M. Zhang, and K. Tracey The Cytokine Handbook 3rd ed. 1988 Academic Press San Diego
40. T. Yamauchi, J. Kamon, H. Waki, and Y. Terauchi The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
41. Fujimoto N, Mouri N, Iwata K, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta. 193;221:91-103.
42. R.A. De Fronzo, J.A. Tobin, and B. Andres Glucose clamp technique, a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 214 223
43. B.J. Winer Statistical Principles in Experimental Design 2nd ed. 1971 McGraw-Hill New York
44. H. Iso, M. Kobayashi, J. Ishihara JPHC Study Group Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I Circulation 113 2006 195 202
45. M. Yokoyama, H. Origasa, M. Matsuzaki Japan EPA lipid intervention study (JELIS) Investigators Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
46. G.G. Abdukeyum, A.J. Owen, and P.L. McLennan Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning J Nutr 138 2008 1902 1909
47. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
48. S. Pepe, and P.L. McLennan (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats J Nutr 137 2007 2377 2383
49. M. Matsumoto, M. Sata, and D. Fukuda Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice Atherosclerosis 197 2008 524 533
50. A.L. Cawood, R. Ding, and F.L. Napper Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability Atherosclerosis 212 2010 252 259
51. M.J. Moreno-Aliaga, S. Lorente-Cebrián, and J.A. Martínez Regulation of adipokine secretion by n-3 fatty acids Proc Nutr Soc 69 2010 324 332
52. A. Alipour, J.W. Elte, H.C. van Zaanen, A.P. Rietveld, and M.C. Cabezas Postprandial inflammation and endothelial dysfunction Biochem Soc Trans 35 2007 466 469
53. J. Constans, and C. Conri Circulating markers of endothelial function in cardiovascular disease Clin Chim Acta 368 2006 33 47
54. Weber PC, Leaf A. Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. In: Simopoulos AP, Kifer RR, Martin RE, et al, eds. Health Effects of w3 Polyunsaturated Fatty Acids in Seafoods. Vol. 66, World Rev Nutr Diet Basel: Karger; 1991:218-232.
55. R.A. Lewis, T.H. Lee, and K.F. Austen Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway A.P. Simopoulos, R.R. Kifer, R.E. Martin, Health Effects of Polyunsaturated Fatty Acids in Seafoods 1986 Academic Press Orlando, FL 227 238
56. A. Leaf, and P.C. Weber Cardiovascular effects of n-3 fatty acids N Engl J Med 318 1988 549 557